Ratings Life Insurance Corporation of India

Equities

LICI

INE0J1Y01017

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-05-10 am EDT			5-day change	1st Jan Change
911 ^INR	+0.98%		-6.97%	+9.42%

May. 09	Life Insurance Corporation of India Provides Update on the order issued by Additional Commissioner, Central GST & Central Excise, Jamshedpur	CI
May. 09	Life Insurance Corporation of India Receives Communication/Demand Order for Goods & Service Tax, Interest and Penalty for Telangana State	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.
The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

The stock, which is currently worth 2024 to 0.62 times its sales, is clearly overvalued in comparison with peers.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

The company's earnings growth outlook lacks momentum and is a weakness.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
LIFE INSURANCE CORPORATION OF INDIA	+9.42%	68.97B	D+
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.	+6.53%	103B	B
CHINA LIFE INSURANCE COMPANY LIMITED	+14.23%	102B	B-
AIA GROUP LIMITED	-5.66%	91.99B	B+
CHINA PACIFIC INSURANCE (GROUP) CO., LTD.	+16.27%	33.18B	B
FUBON FINANCIAL HOLDING CO., LTD.	+10.80%	28.79B	A
JAPAN POST HOLDINGS CO., LTD.	+20.56%	28.74B	B
SBI LIFE INSURANCE COMPANY LIMITED	-0.05%	17.17B	C+
HDFC LIFE INSURANCE COMPANY LIMITED	-15.18%	14.12B	B
NN GROUP N.V.	+27.94%	13.5B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes